Rosuvastatin calcium Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Lipid-regulating drugs | Cardiovascular System
Items (12m)
507
Total Quantity
9,023
NHS Cost
£358
vs National Avg
-43.5%
MAPLE ACCESS PARTNERSHIP LLP prescribed 507 items of Rosuvastatin calcium over the last 12 months at a cost of £358 to the NHS. This is 43.5% below the national average prescribing rate. Rosuvastatin calcium is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jun 2026
37
Jun 2026
34
Jun 2026
40
Jun 2026
38
Jun 2026
37
Jun 2026
47
Jun 2026
39
Jun 2026
49
Jun 2026
45
Jun 2026
48
Jun 2026
49
Jun 2026
44
Prescribing Details
| Total Items | 507 |
|---|---|
| Total Quantity | 9,023 |
| Total NHS Cost | £358 |
| Presentations | 7 different forms |
| vs National Average | -43.5% |
Rosuvastatin calcium Prescribing Comparison
| This practice | 507 items |
|---|---|
| National average per practice | 898 items |
| Difference | -43.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.